Kera Sol eye drops for temporary dry eye after LASIK
Official title: Kera Sol Post-LASIK: A Benefit Study
Run by Vance Thompson Vision · NCT07155070 · Data updated 2026-11-12
This study will test whether using Kera Sol eye drops four times a day for two weeks helps adults who experience temporary dry eye after LASIK.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Vance Thompson Vision Academic / other |
| Locations | 1 site (Sioux Falls, South Dakota) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | December 30, 2026 |
| Study ends | February 1, 2027 |
| Registry record updated | July 13, 2026 |
| Trial ID | NCT07155070 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older undergoing bilateral LASIK who can read and complete questionnaires and are willing to use the study drops and attend follow-up visits.
✕Probably not a fit
Patients already using prescription topical dry-eye medications, with corneal epithelial defects, prior refractive surgery, active ocular infection, or other significant ocular pathology are unlikely to benefit and are excluded from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-site, randomized, two-arm Phase 4 study enrolling 60 adults who underwent bilateral LASIK. All participants will receive the standard postoperative steroid and antibiotic drops, and half will be randomized to add Kera Sol eye drops dosed four times daily for 14 days while the other half receive standard care alone. Signs and symptoms of surgical temporary ocular discomfort syndrome (STODS) will be tracked during the initial two-week postoperative period using clinical exams and patient questionnaires. The study will compare symptom scores and clinical signs between groups to see if Kera Sol improves early recovery.
Why it matters
Potential benefit: If successful, Kera Sol could reduce discomfort and clinical signs of temporary post-LASIK dry eye and speed early visual recovery.
How similar studies have gone: Using lubricating eye drops after LASIK is a common practice and has shown symptom relief in prior reports, but published data specific to Kera Sol are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be willing and able to sign the informed consent form (ICF) * Be at least 18 years of age at the screening visit * Be undergoing LASIK treatment in both eyes * Be literate and able to complete questionnaires independently * Be able and willing to use the study drug and participate in all study assessments and visits * Have provided verbal and written informed consent Exclusion Criteria: * Use of topical prescription dry eye medications such as lifitegrast, cyclosporine, loltilaner, etc. * Have a break in the integrity of the corneal epithelium such as a persistent corneal epithelial defect, or corneal ulcer. * Have presence of corneal pathology that may interfere with LASIK outcomes * Active infectious, ocular or systemic disease * Have a history of ocular inflammation or macular edema * Have had clinically significant active infectious keratitis in the past 3 months 7. -Have history of prior refractive surgery * Have placement of temporary punctal plugs in the past 1 month or current presence of permanent punctal plugs at time of screening * Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled Glaucoma, collagen vascular disorders, keratoconus or signs of keratoconus, uncontrolled Diabetes, Herpes) * Autoimmune or immunodeficiency diseases * Pregnant or nursing women * Patients with history of previous ocular surgery, , except for previous cataract surgery.
Where it's running
-
Vance Thompson Vision Clinic, Prof. LLC
Sioux Falls, South Dakota, United States Recruiting
Study contacts
- Principal investigator: Dan Terveen, MD — Vance Thompson Vision Clinic Prof. LLC
- Study coordinator: Tiffany Facile
- Email: tiffany.facile@vancethompsonvision.com
- Phone: 605-371-7075
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lacrifill to Help Prevent Post-Curgery Dry Eye After Cataract Surgery
This study tests Lacrifill to see if it helps prevent dry eye symptoms after unilateral cataract surgery.
-
Tear-Fluid Stability Testing with iTrace, BOSA, OPD-Scan III, and IDRA for Dry Eye
A Phase 4 study tests whether four eye devices can detect tear film stability in adults with normal tear film.
-
OT202 1% eye drops for moderate to severe dry eye
This phase 3 study tests whether 1% OT202 eye drops help people with moderate to severe dry eye better than a placebo.
-
Tyrvaya Nasal Spray for Comfort in Contact Lens Wearers
This study tests whether using Tyrvaya twice daily can improve comfort for adults who wear soft contact lenses and have dry eye symptoms.
-
Long-term effects of Acoltremon vs. control in dry eye disease
This study tests whether Acoltremon eye drops help people with dry eye over a year compared with a preservative-free artificial tear, at a single center.
-
Effect of Dry Eye Treatment on Corneal Astigmatism Measurements
This study tests whether short-term treatment for dry eye changes how consistently three devices measure corneal astigmatism in people preparing for cataract surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.